saplin

Compare funds

UTI Value vs Templeton India Value

Both are value fund funds. Over the last 3 years UTI Value returned 13.4% a year and Templeton India Value 10.3%, against a category median of 13.4%. UTI Value costs 1.34% a year and Templeton India Value 1.12%. On the saplin Score UTI Value rates 7.0 (Neutral) and Templeton India Value 5.3 (Weak) within their category. 38.9% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

UTI ValueTempleton India ValueCategory median
saplin Score (0–10)7.0 Neutral5.3 Weak—
1-year return-1.3%-3.1%1.0%
3-year return, a year13.4%10.3%13.4%
5-year return, a year11.1%11.9%13.0%
Volatility (standard deviation)15.4%15.0%15.8%
Sharpe ratio0.490.320.49
Beta0.940.910.96
Upside capture9989100
Downside capture949395
Expense ratio (Direct)1.34%1.12%1.17%
Fund size₹9,537 cr₹1,956 cr₹1,804 cr
Number of holdings634762
Top 10 holdings, share of fund42.8%45.5%37.9%
Portfolio P/E20.716.320.7
Lead managerAmit Premchandani (5 yrs)Ajay Argal (3 yrs)—
Launched20 Jul 200510 Sept 1996—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

UTI Value and Templeton India Value have 38.9% of their portfolios in the same stocks (16 holdings in common, portfolios as of 30 Oct 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsUTI ValueTempleton India Value
HDFC Bank7.83%7.79%
ICICI Bank6.66%6.09%
Axis Bank3.93%6.33%
Infosys3.56%3.56%
State Bank of India3.32%3.11%
Reliance Industries2.40%4.91%
Maruti Suzuki India1.78%2.69%
Cipla1.77%3.88%
ITC1.48%2.65%
Power Grid Corporation of India1.92%1.34%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.